BIBLIOGRAPHIC RECORD

Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Zhou W; Liang F; Chen N; Zhang Y; Wang X; Li X; Lu D; Guo F; Yao Y; Zhu J; Shen C; Wang C; Zhang P; Zhao L; Wang Y; Han J; Li W; Wu H; Wang P; Yan Q; Lv Q; Yi Z
Source of metadata
PubMed
Year recorded
2026

Public identifiers and source

Open the source record

Reference

Zhou W; Liang F; Chen N; Zhang Y; Wang X; Li X; Lu D; Guo F; Yao Y; Zhu J; Shen C; Wang C; Zhang P; Zhao L; Wang Y; Han J; Li W; Wu H; Wang P; Yan Q; Lv Q; Yi Z. (2026). Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction. https://pubmed.ncbi.nlm.nih.gov/42755522/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-2d8c2586767349ba51b9e4a28da10526/